Nautilus Biotechnology, Inc.
NAUT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1,619 | $1,633 | $1,625 | $6,353 |
| Gross Profit | -$1,619 | -$1,633 | -$1,625 | -$6,353 |
| % Margin | – | – | – | – |
| R&D Expenses | $9,179 | $9,937 | $11,071 | $10,848 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4,674 | $5,527 | $6,148 | $2,779 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $13,853 | $15,464 | $17,219 | $13,627 |
| Operating Income | -$15,472 | -$17,097 | -$18,844 | -$19,980 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,898 | $2,064 | $2,231 | $2,386 |
| Pre-Tax Income | -$13,574 | -$15,033 | -$16,613 | -$17,594 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$13,574 | -$15,033 | -$16,613 | -$17,594 |
| % Margin | – | – | – | – |
| EPS | -0.11 | -0.12 | -0.13 | -0.14 |
| % Growth | 8.3% | 7.7% | 7.1% | – |
| EPS Diluted | -0.11 | -0.12 | -0.13 | -0.14 |
| Weighted Avg Shares Out | 126,219 | 126,175 | 124,919 | 125,796 |
| Weighted Avg Shares Out Dil | 126,219 | 126,175 | 124,919 | 125,796 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,903 | $2,080 | $2,231 | $2,431 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,619 | $1,633 | $1,625 | $6,353 |
| EBITDA | -$11,955 | -$13,400 | -$14,988 | -$11,241 |
| % Margin | – | – | – | – |